Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2008
The challenge of herbal therapies for prostate cancer
Rupal S Bhatt, Glenn J Bubley
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2014
Molecular pathways: can activin-like kinase pathway inhibition enhance the limited efficacy of VEGF inhibitors?
Rupal S Bhatt, Michael B Atkins
Molecular & Cellular Oncology
|
October 7, 2021
Combining VEGF receptor inhibitors and angiotensin-(1-7) to target renal cell carcinoma
Thomas Walther, Prateek Khanna, Rupal S Bhatt
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2007
Biomarkers for monitoring antiangiogenic therapy
Rupal S Bhatt, Pankaj Seth, Vikas P Sukhatme
Cancer Cell
|
February 12, 2015
Taxane resistance in prostate cancer mediated by AR-independent GATA2 regulation of IGF2
Stephen R Plymate, Rupal S Bhatt, Steven P Balk
Journal for Immunotherapy of Cancer
|
September 14, 2018
Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic
Johannes C Melms, Rohit Thummalapalli, Kristin Shaw, et al.
AJR. American Journal of Roentgenology
|
June 2, 2017
CT Intensity Distribution Curve (Histogram) Analysis of Patients Undergoing Antiangiogenic Therapy for Metastatic Renal Cell Carcinoma
Johannes Boos, Giselle Revah, Olga R Brook, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 26, 2021
Enzalutamide With Radiation Therapy for Intermediate-Risk Prostate Cancer: A Phase 2 Study
Irving Kaplan, Glenn J Bubley, Rupal S Bhatt, et al.
Clinical Genitourinary Cancer
|
October 23, 2013
Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinoma
Peter Beddy, Elizabeth M Genega, Long Ngo, et al.
BJU International
|
April 9, 2008
Hypoxia-inducible factor-2alpha: effect on radiation sensitivity and differential regulation by an mTOR inhibitor
Rupal S Bhatt, Daniel M Landis, Michael Zimmer, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2008
The challenge of herbal therapies for prostate cancer
Rupal S Bhatt, Glenn J Bubley
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2014
Molecular pathways: can activin-like kinase pathway inhibition enhance the limited efficacy of VEGF inhibitors?
Rupal S Bhatt, Michael B Atkins
Molecular & Cellular Oncology
|
October 7, 2021
Combining VEGF receptor inhibitors and angiotensin-(1-7) to target renal cell carcinoma
Thomas Walther, Prateek Khanna, Rupal S Bhatt
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2007
Biomarkers for monitoring antiangiogenic therapy
Rupal S Bhatt, Pankaj Seth, Vikas P Sukhatme
Cancer Cell
|
February 12, 2015
Taxane resistance in prostate cancer mediated by AR-independent GATA2 regulation of IGF2
Stephen R Plymate, Rupal S Bhatt, Steven P Balk
Journal for Immunotherapy of Cancer
|
September 14, 2018
Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic
Johannes C Melms, Rohit Thummalapalli, Kristin Shaw, et al.
AJR. American Journal of Roentgenology
|
June 2, 2017
CT Intensity Distribution Curve (Histogram) Analysis of Patients Undergoing Antiangiogenic Therapy for Metastatic Renal Cell Carcinoma
Johannes Boos, Giselle Revah, Olga R Brook, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 26, 2021
Enzalutamide With Radiation Therapy for Intermediate-Risk Prostate Cancer: A Phase 2 Study
Irving Kaplan, Glenn J Bubley, Rupal S Bhatt, et al.
Clinical Genitourinary Cancer
|
October 23, 2013
Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinoma
Peter Beddy, Elizabeth M Genega, Long Ngo, et al.
BJU International
|
April 9, 2008
Hypoxia-inducible factor-2alpha: effect on radiation sensitivity and differential regulation by an mTOR inhibitor
Rupal S Bhatt, Daniel M Landis, Michael Zimmer, et al.
Page
of 5